Feline Atopic Skin Syndrome (FASS) – Beyond the Itch

Feline Atopic Skin Syndrome (FASS) is a chronic, inflammatory skin condition triggered by environmental allergens such as pollen, dust mites, and molds. Unlike canine atopic dermatitis, FASS has unique clinical presentations and often coexists with other allergic conditions, making diagnosis more challenging¹. 

Cats with FASS may exhibit intense pruritus, self-inflicted alopecia, eosinophilic plaques, and miliary dermatitis, sometimes localized to the head, neck, or ventral abdomen. Unlike dogs, the lesions may be less obvious, and owners may not recognize subtle signs of itch, such as over-grooming or rubbing against furniture. 

Diagnosis and Clinical Approach 

1. Referral Considerations: 

1. Referral to a veterinary dermatologist is highly recommended when FASS is suspected. 

2. Specialists can help identify triggers, optimize therapy, and guide immunotherapy protocols. 

2. Baseline Assessment: 

1. Before starting long-term management, establish a baseline pruritus score. 

2. This provides a reference point to evaluate treatment response over time. 

3. Differential Diagnosis: 

1. FASS is a diagnosis of exclusion. 

2. Rule out ectoparasites, secondary infections, and food allergies before confirming FASS. 

Medical Management Strategies 

1. Glucocorticoids: 

1. First-line therapy for most cats to rapidly reduce inflammation and pruritus. 

2. Options include prednisolone (2 mg/kg/day), methylprednisolone (0.8–1.5 mg/kg/day), or dexamethasone (0.2 mg/kg/day), typically tapered over 3 weeks¹. 

2. Cyclosporine: 

1. Approved for feline allergy management. 

2. Palatability may be a concern, and therapeutic effects typically take 4–6 weeks. 

3. Once stable, dosing can often be reduced to every other day. 

4. Cats on cyclosporine should remain on cooked diets and effective parasite control due to immunosuppressive effects. 

3. Immunotherapy: 

1. Both injectable and sublingual immunotherapy can be effective. 

2. Allergy testing (serum or intradermal) does not diagnose FASS, but helps formulate immunotherapy tailored to the cat. 

3. Cats tend to respond favorably, but owner education and compliance are critical for success. 

4. Other Medications: 

1. Oclacitinib and lokivetmab are not recommended in cats due to limited safety data or species-specific risks. 

2. Antihistamines may be useful for concurrent upper respiratory signs, but are generally ineffective for pruritus alone. 

Adjunctive Therapies 

• Nutraceuticals: Essential fatty acids or palmitoylethanolamide can support skin health. 

• Topical Barrier Support: Fatty acid or essential oil spot-on products may help mild cases or reduce medication requirements, although evidence is limited. 

• Client Support: Technicians can reinforce medication adherence, explain disease chronicity, and guide environmental allergen management. 

Managing Flares 

Even well-controlled cats may experience acute pruritic episodes. During flares: 

• Reassess for ectoparasites, bacterial, or yeast infections. 

• Consider short-term glucocorticoid therapy if pruritus is severe. 

• Temporarily increase cyclosporine dosing if already prescribed. 

• Reassure owners that flares do not indicate treatment failure, but may require additional supportive measures¹. 

Key Takeaways 

• FASS is a lifelong, chronic condition that requires structured management and strong client communication. 

• Glucocorticoids and cyclosporine form the foundation of therapy, while immunotherapy offers long-term disease modification. 

• Adjuncts like nutraceuticals and topical therapies can support overall skin health. 

• Owner education and compliance are essential for optimal outcomes and maintaining trust. 

Reference  

1. Miller J, Simpson A, Bloom P, Diesel A, Friedeck A, Paterson T, Wisecup M, Yu CM. 2023 AAHA management of allergic skin diseases in dogs and cats guidelines. Journal of the American Animal Hospital Association. 2023 Nov 1;59(6):255-84. https://www.aaha.org/wp-content/uploads/globalassets/02-guidelines/2023-aaha-management-of-allergic-skin-diseases-in-dogs-and-cats-guidelines/resources/2023-aaha-management-of-allergic-skin-diseases-guidelines.pdf.